Swinging Copy and Sober Science

Abstract

The subscription price of the Journal is some 70 per cent less than cost because of income derived from pharmaceutical advertising. This fact does not affect the Journal's contents but has been criticized as influencing medical practice to the advantage of the industry and disadvantage of the patient.